11 July 2018 - Deborah Wilkes
Archived
Pfizer is separating its Consumer Healthcare business from its prescription medicine businesses as part of a major reorganisation. The move comes as Pfizer continues to evaluate strategic alternatives for its Consumer Healthcare business including spin-offs and joint ventures.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.